- Ruling will confirm European regulatory exclusivity for Rubraca until at least 2028
- Clovis also recently received a patent for using Rubraca in high doses to treat cancer in the US... read more
Proteintech, the benchmark in antibodies since 2001, and BenchSci, a life science machine learning startup backed by Google’s AI fund, have announced a new partnership to accelerate science by... read more
Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health... read more
ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, announced on 12/3/18 that it has entered a... read more
